Cisplatin vs carboplatin ototoxicity

Author: cggv

August undefined, 2024

WebAug 19, 2007 · Pooling the results of all of these cis vs. carbo studies together, the response rate with cisplatin combinations was higher (30% vs. 24%), and the overall survival … WebCisplatin has dramatically improved the survival rate of cancer patients, but it has also increased the prevalence of hearing and neurological deficits in this population. Cisplatin induces ototoxicity, peripheral (most prevalent) and central (rare) neurotoxicity.

The side effects of platinum-based chemotherapy drugs: a review …

WebJul 3, 2024 · Cisplatin is a widely used chemotherapeutic agent with a high degree of ototoxicity and an average incidence of over 60% ( Karasawa and Steyger, 2015 ). Ototoxicity depends on several factors, including patient age, cumulative dose of cisplatin, and genetic susceptibility ( Landier, 2016; Lanvers-Kaminsky and Ciarimboli, 2024 ). WebFeb 26, 2024 · The cisplatin ototoxicity occurs between 23% and 50% in adults and up to 60% in children [4,6]. However, some studies have reported elevated hearing thresholds in up to 100% of cisplatin-treated cancer patients [7,8], while it is estimated to be 63% with aminoglycosides and 6-7% with furosemide [9]. greenhouse classes near me

Ototoxicity: A Challenge in Diagnosis and Treatment - PMC

WebThe antineoplastic agent's cisplatin and carboplatin are widely used as they are highly effective. Unfortunately, ototoxicity is a frequently encountered side effect of platinum-based chemotherapy. Clinically, patients generally develop a progressive, bilateral, and irreversible sensorineural hearing loss. WebJan 1, 2024 · Regarding the frequency of ototoxicity of antineoplastic drugs and the dose required to trigger these effects, an important heterogeneity was observed. The frequency of ototoxicity caused by cisplatin ranged from 45% to 83.3% and, when used in combination with carboplatin, ranged from 16.6% to 75%. WebSep 20, 2024 · The incidence of hearing loss was lower in the sodium thiosulfate and cisplatin arm (39%) compared with the cisplatin alone arm (68%); unadjusted relative risk 0.58 (95% CI: 0.40, 0.83). greenhouse clamps

A Comparison of the Toxicity and Efficacy of Cisplatin and …

Cancers Free Full-Text Nonsurgical Treatment Strategies for …

WebNational Center for Biotechnology Information WebMar 29, 2024 · Platinum-based agents are a standard chemotherapy treatment for malignancies in both pediatric and adult populations. 1 However, mitigating and managing chemotherapy-associated adverse events remains a concern. 2 Ototoxicity is a well-documented side effect of these platinum-based agents, especially cisplatin. This … greenhouse clamps australiaWebThe dose-limiting side effect for cisplatin is nephrotoxicity, for carboplatin it is myelosuppression, and for oxaliplatin it is neurotoxicity. Other common side effects … fly away buses

"WebPlatinum was measured in 46 serum samples from our blood collection pilot study. Three platinum isotopes were measured with consistent measurements across isotopes. Platinum levels ranged from 0.030 ug/L to 0.87ug/L at time points from 6-13 years after diagnosis with higher levels in cases who received chemotherapy (0.19ug/L vs 0.07ug/L, p=0.002). " - Cisplatin vs carboplatin ototoxicity

Cisplatin vs carboplatin ototoxicity

The side effects of platinum-based chemotherapy drugs: a review …

WebA Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors: Actual Study Start Date ... [PROs] of ototoxicity) Note: participants in group 1 will not receive AGCT1531 protocol-directed therapy; all other AYA-HEARS patients must be ... WebMar 25, 2024 · The aim of this study is to evaluate the current state of ototoxicity monitoring for patients receiving cisplatin chemotherapy in an academic medical center with particular attention to how closely monitoring adheres to national ototoxicity guidelines. Case series including retrospective medical records review of patients (age > 18) treated …

Did you know?

http://mdedge.ma1.medscape.com/obgyn/article/97636/gynecologic-cancer/paclitaxel-carboplatin-should-be-standard-option-advanced WebMar 31, 2024 · Metal-based complexes contribute a vital part in the available arsenal of cytotoxic agents today. Platinum (II) complexes, specifically targeting genomic DNA (e.g., cisplatin and carboplatin), are widely used in the clinic for the treatment of various cancers. Nearly 50% of cancer patients, who undergo chemotherapy, receive a platinum …

WebIbero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin Javascript is currently disabled in your browser. Several features of this site will not function whilst javascript is disabled. WebOtotoxicity of cisplatin as a single therapeutic agent is well documented. Less is known, however, about its interaction with other drugs and/or cranial irradiation. For example, ifosfamide, given as a single agent, is not known to be ototoxic but appears to potentiate the ototoxicity of cisplatin ( McHaney et al., 1992 ).

WebMar 3, 2015 · Key clinical point: Paclitaxel plus carboplatin is noninferior to paclitaxel plus cisplatin for metastatic or recurrent cervical cancer. Major finding: The carboplatin regimen, with a median overall survival of 17.5 months, proved to be noninferior to the cisplatin regimen, which had a median OS of WebCis-diamminedichloroplatinum (cisplatin), a divalent platinum compound and cell-cycle nonspecific chemotherapeutic agent, produces a permanent high-frequency …

WebApr 26, 2024 · Tumors treated by cisplatin include adults with head and neck cancer and testicular, ovarian and lung cancers. Cisplatin is a key chemotherapeutic agent used to … flyaway broadcast systemWebThe platinum-based drugs cisplatin, carboplatin and oxaliplatin are regularly prescribed in the treatment of cancer and while they are effective, their use is limited by their severe, dose-limiting side effects (also referred to as adverse effects/events). In total, a cancer patient can experience any combination of around 40 specific side effects. flyaway bus lax to union station costWebFinal results indicate that the investigational chemotherapeutic analogs CBDCA (JM-8) and CHIP (JM-9) do not produce the ototoxicity and nephrotoxicity characteristic of cisplatin. Furthermore, these findings demonstrate 195mpt localization in the vestibular labyrinth and confirm previous platinum distribution studies in the organ of Corti and ... flyaway bus serviceWebOct 8, 2010 · Carboplatin, a therapeutic alternative to cisplatin, has been shown to be less ototoxic, with reported toxicity rates of 0–38% [ 4, 10 – 12, 18, 19 ]. Carboplatin is also … fly away bus at union stationWebEfficacy and safety of a cisplatin and paclitaxel (TP) induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC) flyaway bus from lax to union station ticketWebBesides myelosuppression, nephrotoxicity and ototoxicity are dose-limiting for cisplatin, whereas thrombocytopenia is dose-limiting for carboplatin. Cisplatin is extensively bound to plasma proteins and clear pharmacokinetic-PD correlations have been identified for the ultrafiltrable, i.e., unbound fraction of the drug in plasma and toxicity as ... greenhouse cleaners half moon bayWebCarboplatin. Cisplatin. Loop diuretics (water pills) Loop diuretics help your kidneys move excess salt and fluid out of your body. Ototoxic types include: Bumetanide. Ethacrynic acid. Furosemide. Torsemide. Other ototoxic drugs and chemicals Rarer causes of ototoxicity include: Quinine: Drugs providers use to treat malaria. flyaway bus los angeles airport